A remedy for biomarker addiction: back to rational anticancer drug development
Nat Clin Pract Oncol
.
2007 May;4(5):264-5.
doi: 10.1038/ncponc0811.
Authors
Hagop Youssoufian
1
,
Eric K Rowinsky
Affiliation
1
ImClone Systems Incorporated, Branchburg, NJ 08876, USA. hagop.youssoufian@imclone.com
PMID:
17464335
DOI:
10.1038/ncponc0811
No abstract available
MeSH terms
Antineoplastic Agents / pharmacology*
Biomarkers / analysis*
Drug Design*
Drug Industry
Humans
Substances
Antineoplastic Agents
Biomarkers